» Articles » PMID: 36658107

Hepatocyte Growth Factor-mediated Apoptosis Mechanisms of Cytotoxic CD8 T Cells in Normal and Cirrhotic Livers

Overview
Date 2023 Jan 19
PMID 36658107
Authors
Affiliations
Soon will be listed here.
Abstract

Intrahepatic stem/progenitor cells and cytotoxic CD8 T cells (CD8 T cells) in the cirrhotic liver undergo apoptosis, which potentially facilitates progression to cancer. Here, we report that hepatocyte growth factor (HGF) signaling plays an important role in promoting normal and damaged liver CD8 T cell Fas-mediated apoptosis through its only receptor, c-Met. In addition to binding with HGF, c-Met also binds to Fas to form a complex. Using a diethylnitrosamine (DEN)-induced liver fibrosis/cirrhosis mouse model, immunostaining, and terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) staining, we found that HGF secretion was significantly higher at 10 weeks post-DEN, the liver cirrhotic phase (LCP), than at 3 weeks post-DEN, the liver fibrotic phase (LFP). Correspondingly, differences in CD8 T cell proliferation and apoptosis were noted between the two phases. Interestingly, staining and TUNEL assays revealed lower smooth muscle actin (α-SMA) cell apoptosis, a marker for hepatic stellate cells (HSCs), in the LFP group than in the LCP group, which suggested a beneficial correlation among HGF, CD8 T cells and HSCs in improving the fibrotic load during damaged liver repair. In cultures, when met different concentrations of recombinant HGF (rHGF), phytohemagglutinin (PHA)-stimulated naive mouse splenic CD8 T cells (pn-msCD8 T cells) responded differently; as increases in rHGF increased were associated with decreases in the clonal numbers of pn-msCD8 T cells, and when the rHGF dose was greater than 200 ng/mL, the clonal numbers significantly decreased. In the presence of 400 ng/mL rHGF, the death-inducing signaling complex (DISC) can be directly activated in both nsCD8 T cells and healthy human peripheral blood CD8 T cells (hp-CD8 T cells), as indicated by recruitment of FADD and caspase-8 because DISC forms via the recruitment of FADD and caspase-8, among others. These findings suggest that Fas-mediated apoptosis, may also indicate a regulatory role of HGF signaling in hepatic homeostasis.

Citing Articles

Development and validation of biomarkers related to anoikis in liver cirrhosis based on bioinformatics analysis.

Luo J, Zheng S, Yang J, Ma C, Ma X, Wang X World J Hepatol. 2024; 16(11):1306-1320.

PMID: 39606164 PMC: 11586749. DOI: 10.4254/wjh.v16.i11.1306.


Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment.

Yao S, Liu X, Feng Y, Li Y, Xiao X, Han Y Int J Mol Sci. 2024; 25(16).

PMID: 39201787 PMC: 11354629. DOI: 10.3390/ijms25169101.


Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance.

Chen Q, Yang Z, Lin H, Lai J, Hu D, Yan M Front Immunol. 2023; 14:1162439.

PMID: 37614233 PMC: 10444199. DOI: 10.3389/fimmu.2023.1162439.


differentiated human CD4 T cells produce hepatocyte growth factor.

Ford S, Buus T, Nastasi C, Geisler C, Bonefeld C, Odum N Front Immunol. 2023; 14:1210836.

PMID: 37520551 PMC: 10374024. DOI: 10.3389/fimmu.2023.1210836.

References
1.
Trusolino L, Comoglio P . Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer. 2002; 2(4):289-300. DOI: 10.1038/nrc779. View

2.
Huh C, Factor V, Sanchez A, Uchida K, Conner E, Thorgeirsson S . Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A. 2004; 101(13):4477-82. PMC: 384772. DOI: 10.1073/pnas.0306068101. View

3.
Michalopoulos G, Defrances M . Liver regeneration. Science. 1997; 276(5309):60-6. DOI: 10.1126/science.276.5309.60. View

4.
Liu X, Mi X, Wang Z, Zhang M, Hou J, Jiang S . Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway. Cell Death Dis. 2020; 11(6):454. PMC: 7293224. DOI: 10.1038/s41419-020-2597-7. View

5.
OConnell J, OSullivan G, Collins J, Shanahan F . The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med. 1996; 184(3):1075-82. PMC: 2192789. DOI: 10.1084/jem.184.3.1075. View